comparemela.com

Latest Breaking News On - Atea pharmaceuticals inc - Page 7 : comparemela.com

Atea Pharmaceuticals, Inc (NASDAQ:AVIR) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals Third Quarter 2023 Financial Results and Business Update Conference Call. [Operator Instructions].

Atea Pharmaceuticals (AVIR) Set to Announce Quarterly Earnings on Wednesday

Atea Pharmaceuticals (NASDAQ:AVIR – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, November 8th. Analysts expect the company to announce earnings of ($0.46) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link. Atea Pharmaceuticals […]

Atea Pharmaceuticals, Inc (NASDAQ:AVIR) Short Interest Up 8 5% in September

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Get Free Report) saw a significant increase in short interest in September. As of September 15th, there was short interest totalling 1,920,000 shares, an increase of 8.5% from the August 31st total of 1,770,000 shares. Currently, 2.6% of the company’s stock are short sold. Based on an average daily trading […]

Auour Investments LLC Acquires New Position in Atea Pharmaceuticals, Inc (NASDAQ:AVIR)

Auour Investments LLC bought a new position in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 177,000 shares of the company’s stock, valued at approximately $662,000. Auour Investments LLC owned about 0.21% of […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.